TVM Capital Life Science
Jijimon Augustine has been serving as Chief Financial Officer at TVM Capital Healthcare Partners Limited since April 2010. Previously, Jijimon held the position of Group Finance Director at various reputable companies such as Ameco Medical Industries, Cambridge Medical & Rehabilitation Center, Manzil Healthcare Services Limited, Bourn Hall Fertility Centre Dubai, and ProVita International Medical Center. Jijimon also worked as a Finance Manager at Gulf Healthcare International LLC. Jijimon holds a Master of Business Administration (M.B.A.) degree in Finance and Marketing, as well as Master’s and Bachelor’s degrees in Business/Commerce from MG University in India.
This person is not in any offices
TVM Capital Life Science
TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics. The TVM investment team has worked together for over a decade to effectively utilize this innovative approach to maximize returns for investors and finance new therapies and technologies to meaningfully improve patient lives.